Compugen (CGEN) SVP uses 10b5-1 plan to exercise options and sell shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
COMPUGEN LTD senior vice president of business development Zurit Levine exercised stock options and sold shares in a planned transaction. She exercised options for 11,875 ordinary shares at an exercise price of $0.8292 per share, then sold 11,875 ordinary shares at a weighted average price of $2.0368 per share.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 23, 2025, indicating it was scheduled in advance rather than timed discretionarily. Following these transactions, Levine holds 29,375 ordinary shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 11,875 shares ($24,187)
Net Sell
3 txns
Insider
Levine Zurit
Role
SVP, Business Development
Sold
11,875 shs ($24K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (right to buy) | 11,875 | $0.00 | -- |
| Exercise | Ordinary Shares | 11,875 | $0.8292 | $10K |
| Sale | Ordinary Shares | 11,875 | $2.0368 | $24K |
Holdings After Transaction:
Share Option (right to buy) — 16,125 shares (Direct);
Ordinary Shares — 41,250 shares (Direct)
Footnotes (1)
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Options exercised: 11,875 shares
Option exercise price: $0.8292 per share
Shares sold: 11,875 shares
+3 more
6 metrics
Options exercised
11,875 shares
Share Option (right to buy) exercised on March 26, 2026
Option exercise price
$0.8292 per share
Exercise price for 11,875 underlying ordinary shares
Shares sold
11,875 shares
Open-market sale of ordinary shares on March 26, 2026
Weighted average sale price
$2.0368 per share
Sale price for 11,875 ordinary shares, multiple trades $2.02–$2.10
Post-transaction holdings
29,375 shares
Ordinary shares directly owned after transactions
Option expiration
November 9, 2032
Expiration date of exercised share option grant
Key Terms
Rule 10b5-1 trading plan, Share Option (right to buy), Exercise or conversion of derivative security, weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
weighted average price financial
"The price reported is a weighted average price. These shares were sold..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transactions did COMPUGEN (CGEN) SVP Zurit Levine report?
Zurit Levine reported exercising options for 11,875 ordinary shares and selling 11,875 ordinary shares. The exercise price was $0.8292 per share, and the sale used a weighted average price of $2.0368 per share on the same date.
What prices were involved in Zurit Levine’s CGEN Form 4 transactions?
The options were exercised at an exercise price of $0.8292 per share. The 11,875 ordinary shares were then sold at a weighted average price of $2.0368 per share, with individual trades ranging from $2.02 to $2.10 inclusive.
What type of derivative security did Zurit Levine exercise at COMPUGEN (CGEN)?
She exercised a “Share Option (right to buy)” covering 11,875 underlying ordinary shares. The option had an exercise price of $0.8292 per share and an expiration date of November 9, 2032, according to the Form 4 details.